Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial dosage selection of antiarrhythmic therapy.

L A Siddoway1

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

The American Journal of Cardiology
|October 19, 1988
PubMed
Summary

Choosing the right antiarrhythmic drug dosage is crucial for effective treatment. Proper dose titration, guided by patient response and drug levels, helps avoid treatment failure and toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immediate- versus controlled-release disopyramide: importance of saturable binding.

Clinical pharmacology and therapeutics·1993
Same author

Selecting appropriate first-line antiarrhythmic agents: comparative pharmacological profiles.

Pacing and clinical electrophysiology : PACE·1990
Same author

Pharmacokinetics of recombinant human superoxide dismutase.

Journal of cardiovascular pharmacology·1990
Same author

Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.

The Journal of clinical investigation·1990
Same author

Clinical pharmacokinetics of moricizine.

The American journal of cardiology·1990
Same author

Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.

Clinical pharmacology and therapeutics·1989

Area of Science:

  • Pharmacology
  • Cardiology
  • Clinical Therapeutics

Background:

  • Antiarrhythmic drug therapy success hinges on appropriate initial dosage selection.
  • Suboptimal dosing can lead to delayed arrhythmia suppression or intolerable toxicity.
  • Individual patient factors significantly influence drug disposition and response.

Purpose of the Study:

  • To emphasize the importance of initial dosage selection in antiarrhythmic drug therapy.
  • To outline a rational approach to antiarrhythmic drug dosing and titration.
  • To highlight factors influencing drug pharmacokinetics and the need for individualized dosing.

Main Methods:

  • Review of principles of antiarrhythmic drug therapy and dosage adjustment.
  • Discussion of factors affecting drug pharmacokinetics, including disease and drug interactions.
  • Emphasis on clinical response and plasma drug concentrations for guiding dose titration.

Main Results:

  • Initial dosage selection significantly impacts treatment outcomes, affecting efficacy and safety.
  • Dose titration, guided by clinical response and drug levels, is essential for optimizing therapy.
  • Interindividual pharmacokinetic variability necessitates dosage modifications based on patient-specific factors.

Conclusions:

  • Successful antiarrhythmic drug treatment requires careful initial dosage selection and individualized titration.
  • Understanding factors influencing drug disposition is key to avoiding dosing errors.
  • Personalized antiarrhythmic drug therapy enhances treatment success and patient safety.

Related Experiment Videos